Gender Dysphoria and Gender Reassignment Surgery – Medicare Advantage Medical Policy | UHC Coverage Update

TL;DR: UnitedHealthcare modified its gender dysphoria and gender reassignment surgery coverage policy, effective November 2, 2025. Here's what billing teams need to do.

UnitedHealthcare updated its coverage policy for gender dysphoria and gender reassignment surgery, deferring to CMS National Coverage Determination NCD 140.9 and local coverage determinations for Medicare Advantage members. The policy governs 146 CPT codes spanning female-to-male procedures (CPT 55980, 58150, 19303, and others), male-to-female procedures (CPT 55970, 57291, 57292, and others), and a broad set of ancillary surgical codes. If your practice bills gender-affirming surgery under UnitedHealthcare, this update changes how you document medical necessity and which coverage rules apply by geography.

Quick-Reference Table

UnitedHealthcare Gender Reassignment Surgery Coverage Criteria and Medical Necessity Requirements 2025

The UnitedHealthcare gender dysphoria coverage policy hinges on a two-track system. For Medicare Advantage members, coverage follows CMS NCD 140.9 — and that NCD contains a critical nuance your billing team must understand.

CMS did not issue a national coverage determination approving or denying gender reassignment surgery. Instead, CMS left coverage decisions to local Medicare Administrative Contractors (MACs). Each MAC makes coverage determinations case-by-case under Section 1862(a)(1)(A) of the Social Security Act.

That means medical necessity criteria are not uniform. A claim for CPT 55980 (female-to-male intersex surgery) or CPT 55970 (male-to-female intersex surgery) may be covered under one MAC jurisdiction and denied under another. Your reimbursement outcome depends entirely on which MAC covers your geographic area.

Where local coverage determinations (LCDs) or local coverage articles (LCAs) exist, compliance with those policies is required. UHC specifies this directly. If you're billing in a jurisdiction with an active LCD, that LCD governs — not UHC's commercial standards.

For states and territories with no applicable LCD or LCA, UHC directs payers to its own UnitedHealthcare Commercial Medical Policy titled "Gender Dysphoria Treatment." That's your fallback document. Pull it. Read it. Know whether your state has an LCD before you assume the commercial policy applies.

Cross-sex hormone therapy may also be covered as part of gender dysphoria treatment. Coverage splits between Part B and Part D depending on how and where the medication is administered. For hormone therapy billing, refer separately to UHC's Medicare Advantage Medical Policy titled "Medications/Drugs (Outpatient/Part B)." Do not assume Part B coverage for all hormone therapy — the Part B vs. Part D distinction will drive claim denials if you get it wrong.

Prior authorization requirements are not explicitly detailed in this policy update. Given the complexity of these procedures and the LCD-dependent coverage structure, treat prior authorization as required until you confirm otherwise with your MAC or UHC provider relations contact.

Coverage Indications at a Glance

UnitedHealthcare Gender Reassignment Surgery Billing Guidelines and Action Items 2025

1. Identify your MAC and check for active LCDs before November 2, 2025.
Go to the CMS LCD database and confirm whether your jurisdiction has an active LCD or LCA for gender dysphoria and gender reassignment surgery. This is the single most important step. Your billing guidelines change based on that answer.

2. Pull the correct coverage document based on your jurisdiction.
If an LCD or LCA exists, that document controls your medical necessity criteria, documentation requirements, and covered CPT codes. If no LCD exists, pull UHC's "Gender Dysphoria Treatment" commercial medical policy and apply those criteria.

3. Audit your charge capture for the 146 CPT codes in this policy.
This policy spans three code groups: female-to-male procedures, male-to-female procedures, and ancillary surgical services. Review your charge capture to make sure CPT codes like 55980, 55970, 57291, 19303, 58150, and the full list of ancillary codes (flaps, grafts, dermabrasion) are mapped correctly to the right group and diagnosis.

4. Separate hormone therapy claims by Part B vs. Part D.
Do not lump hormone therapy under a single billing pathway. Determine how each medication is administered and apply the correct coverage track. A Part D drug billed to Part B is a claim denial waiting to happen.

5. Confirm prior authorization requirements with UHC directly.
This policy does not spell out prior auth requirements in the update. That absence is not permission to skip authorization. Call your UHC provider relations contact or check the UHC portal for prior authorization requirements specific to the procedure codes you bill.

6. Talk to your compliance officer if your patient population crosses MAC jurisdictions.
If your practice sees patients across state lines or you bill under multiple MACs, the patchwork nature of this LCD-dependent policy creates real compliance exposure. Your compliance officer needs to map which rules apply in each jurisdiction before the effective date.

CPT, HCPCS, and ICD-10 Codes for Gender Dysphoria and Gender Reassignment Surgery Under NCD 140.9

Female-to-Male Procedures — CPT Codes

Male-to-Female Procedures — CPT Codes

Other Ancillary Services — CPT Codes

Note on CPT 15819: This code was deleted effective December 31, 2024. Remove it from your charge capture immediately if it still appears in your system. Billing a deleted code guarantees a claim denial.

Note on ICD-10-CM codes: The policy document lists 72 ICD-10-CM codes in its code table. The specific codes were not available in the source data for this update. Pull the full code list directly from the UHC policy document at app.payerpolicy.org/p/uhc/gender-dysphoria-gender-reassignment-surgery to verify the complete ICD-10 diagnosis code list for gender dysphoria billing.

The Real Issue With This Policy Update

Here's what this policy does not do: it does not give you a clean, uniform set of medical necessity criteria. That's a problem.

The LCD-dependent structure means your billing team cannot apply a single standard across your patient population. A practice in a MAC jurisdiction with an active local coverage determination faces different documentation requirements than a practice in a state with no LCD. The commercial policy fallback adds a third standard for non-Medicare members.

Gender reassignment surgery billing is already high-stakes. These procedures carry significant reimbursement, require extensive documentation, and draw close scrutiny on audit. A claim for CPT 57291 (vaginal construction without graft) or CPT 58571 (laparoscopic total hysterectomy with removal of tubes and ovaries) that doesn't meet your specific MAC's medical necessity criteria will not just deny — it can trigger a broader review.

The UHC commercial plan members in states with no LCD get routed to the "Gender Dysphoria Treatment" commercial medical policy. Confirm with your UHC provider relations team which policy applies for each member before services are rendered.

If your organization performs these procedures across multiple states, your compliance officer should map each location to its governing LCD before the November 2, 2025 effective date — and document that mapping.